(April 17, 2009) Exco InTouch, the leading provider of patient communication solutions for the pharmaceutical and healthcare sectors, announces that the company will co-host two informative seminars examining the impact new technology has had on patient engagement in clinical trials. The first event will be held at the Marriott Downtown, Philadelphia, US on April 21 2009. A UK event will follow on May 13, 2009 at The Cumberland Hotel in London. Delegates can register for these events by visiting www.regonline.com/ePRO_Philadelphia (Philadelphia) and www.regonline.com/ePRO_London (London). The seminar series is also being led by ERT, a leading provider of centralized ECG and eClinical technology, ePRO and services to the biopharmaceutical, medical device and related industries.
The half-day seminars, entitled 'The Complete Patient Experience throughout the Trial Lifecycle', will feature interactive discussions led by key industry figures. Exco InTouch CEO Tim Davis will examine the issues of cell phone technology, security and patient confidentiality and the future of new clinical trial technologies. Exco InTouch will also share several real-world retention and ePRO case studies to demonstrate the benefits of cell phone technology for use in clinical trials. Exco InTouch representatives will be on hand at the seminar to give an overview of how the company is harnessing the power of a patient's own cell phone to deliver eDiaries-a more successful and cost-effective alternative to other methods of data collection.
Ken Kaitin, Director and Professor of Medicine Tufts Center for the Study of Drug Development at TUFTS University in Massachusetts, will deliver a keynote address at both seminars entitled 'Pharmaceutical Innovation at a Crossroads: Economic and Political Perspectives on the New Drug Development Process'. Other speakers at the event will include John H. Greist, Director at Healthcare Technology Systems Inc, who will be discussing Interactive Voice Response technology in suicidality assessments.
Exco InTouch's cell phone-based electronic Patient Reported Outcomes (ePRO), recruitment, retention and compliance offerings have already helped several large pharmaceutical companies to enhance clinical trial communications and substantially improve data capture.
For further information on the Exco InTouch seminar series and the company's extensive portfolio of patient communication solutions please call +44 1279 408 210 or +1 949 725 2946 or visit www.excointouch.com. Alternatively, please email info@excointouch.com
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.